Cidara Corporate Presentation - October 2020
(WorldNews Japan)

New Hope for Serious Infections Corporate Presentation October 2020 © Cidara Therapeutics 2020 Forward-looking statements potential for long-term single dose protection, and a broad safety margin; and These slides contain sales, and whether it will be more valuable than other whether Cidara`s Cloudbreak platform will identify AVCs resulting in therapies that are fast acting and types of anti-infectives; statements about the potential forward-looking effectiveness, safety, and long-acting nature long acting; whether Cidara`s HIV approach will yield similar results in its coronavirus AVCs, and of rezafungin, whether preclinical tissue penetration whether Cidara can successfully identify AVCs...